Search research articles
Contact Us
Filters
Showing results (1-10 of 125) with videos related to
Page
of 13
Sort By:
Biochemical Pharmacology
|
March 29, 2003
Effects of D3.49A, R3.50A, and A6.34E mutations on ligand binding and activation of the cannabinoid-2 (CB2) receptor
Wenke Feng, Z H Song
FEBS Letters
|
November 6, 2002
Absence of a conserved proline and presence of a conserved tyrosine in the CB2 cannabinoid receptor are crucial for its function
Z H Song, Wenke Feng
Mini Reviews in Medicinal Chemistry
|
July 14, 2007
Diabetes and metallothionein
Xiaokun Li, Lu Cai, Wenke Feng
Liver Research
|
April 19, 2021
Microbiome dysbiosis and alcoholic liver disease<sup>☆</sup>
Fengyuan Li, Craig J McClain, Wenke Feng
Biochemical and Biophysical Research Communications
|
June 26, 2007
Metallothionein rescues hypoxia-inducible factor-1 transcriptional activity in cardiomyocytes under diabetic conditions
Wenke Feng, Yuehui Wang, Lu Cai, et al.
Gastroenterology Research and Practice
|
February 4, 2016
Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms
Fengyuan Li, Kangmin Duan, Cuiling Wang, et al.
Protein Expression and Purification
|
December 4, 2002
Expression of CB2 cannabinoid receptor in Pichia pastoris
Wenke Feng, Jian Cai, William M Pierce, et al.
Toxicology Letters
|
May 13, 2009
Stable overexpression of human metallothionein-IIA in a heart-derived cell line confers oxidative protection
Wanli Xue, Qiuqu Liu, Lu Cai, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 24, 2006
Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway
Kevyn E Merten, Youchun Jiang, Wenke Feng, et al.
Gastroenterology Research and Practice
|
June 2, 2016
The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background
Jinsheng Yu, Sharon Marsh, Junbo Hu, et al.
Page
of 13
Search research articles
Search
Showing results (1-10 of 125) with videos related to
Sort By:
Page
of 13
Biochemical Pharmacology
|
March 29, 2003
Effects of D3.49A, R3.50A, and A6.34E mutations on ligand binding and activation of the cannabinoid-2 (CB2) receptor
Wenke Feng, Z H Song
FEBS Letters
|
November 6, 2002
Absence of a conserved proline and presence of a conserved tyrosine in the CB2 cannabinoid receptor are crucial for its function
Z H Song, Wenke Feng
Mini Reviews in Medicinal Chemistry
|
July 14, 2007
Diabetes and metallothionein
Xiaokun Li, Lu Cai, Wenke Feng
Liver Research
|
April 19, 2021
Microbiome dysbiosis and alcoholic liver disease<sup>☆</sup>
Fengyuan Li, Craig J McClain, Wenke Feng
Biochemical and Biophysical Research Communications
|
June 26, 2007
Metallothionein rescues hypoxia-inducible factor-1 transcriptional activity in cardiomyocytes under diabetic conditions
Wenke Feng, Yuehui Wang, Lu Cai, et al.
Gastroenterology Research and Practice
|
February 4, 2016
Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms
Fengyuan Li, Kangmin Duan, Cuiling Wang, et al.
Protein Expression and Purification
|
December 4, 2002
Expression of CB2 cannabinoid receptor in Pichia pastoris
Wenke Feng, Jian Cai, William M Pierce, et al.
Toxicology Letters
|
May 13, 2009
Stable overexpression of human metallothionein-IIA in a heart-derived cell line confers oxidative protection
Wanli Xue, Qiuqu Liu, Lu Cai, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 24, 2006
Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway
Kevyn E Merten, Youchun Jiang, Wenke Feng, et al.
Gastroenterology Research and Practice
|
June 2, 2016
The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background
Jinsheng Yu, Sharon Marsh, Junbo Hu, et al.
Page
of 13